FDMDF (4DMedical) Beginning Cash Position: $4.57 Mil (As of Dec. 2025)


FDMDF 4DMedical Ltd FDMDF
46 GF Score
Price $2.80
GF Value $0.87
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is 4DMedical Beginning Cash Position?

4DMedical FDMDF -6.67% 46 Beginning Cash Position is $4.57 Mil as of Dec. 2025. GuruFocus rates FDMDF with a GF Score™ of 46/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 2 warning signs investors should review.

4DMedical's Beginning Cash Position for the quarter that ended in Dec. 2025 was $4.57 Mil.

4DMedical's quarterly Beginning Cash Position declined from Dec. 2024 ($19.38 Mil) to Jun. 2025 ($10.39 Mil) and declined from Jun. 2025 ($10.39 Mil) to Dec. 2025 ($4.57 Mil).

4DMedical's annual Beginning Cash Position increased from Jun. 2023 ($34.30 Mil) to Jun. 2024 ($46.20 Mil) but then declined from Jun. 2024 ($46.20 Mil) to Jun. 2025 ($19.93 Mil).

4DMedical Beginning Cash Position Related Terms

4DMedical Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for 4DMedical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4DMedical Beginning Cash Position Chart

4DMedical Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial 6.44 56.84 34.30 46.20 19.93

4DMedical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.57 31.79 19.38 10.39 4.57
FDMDF
46GF Score
4DMedical Ltd FDMDF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4DMedical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $4.57 Mil mean?
4DMedical (FDMDF) has a Beginning Cash Position of $4.57 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on 4DMedical and its competitors.
Is 4DMedical's Beginning Cash Position too high?
4DMedical's current Beginning Cash Position is $4.57 Mil. Overall, 4DMedical has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Beginning Cash Position compare to ABT and SYK?
4DMedical's Beginning Cash Position of $4.57 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on 4DMedical and its competitors. 4DMedical's current Beginning Cash Position is $4.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (FDMDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $2.80 — trading 221.8% above its estimated fair value. The current Beginning Cash Position is $4.57 Mil. 4DMedical's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For 4DMedical (FDMDF), the current Beginning Cash Position is $4.57 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 4DMedical (FDMDF) Overvalued in 2026?

Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued. The current stock price of $2.80 is trading 221.8% above its estimated GF Value™ of $0.87. GuruFocus considers 4DMedical to be Significantly Overvalued.

Key valuation signals for FDMDF:

  • Beginning Cash Position: $4.57 Mil
  • GF Value™: $0.87 vs. price of $2.80 (221.8% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the FDMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

4DMedical Business Description

Other Exchanges MQ7:Germany4DX:Australia
Address 700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
46GF Score

Get the complete analysis for FDMDF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.80
Price
$0.87
GF Value